Journal of Clinical Pediatrics ›› 2022, Vol. 40 ›› Issue (10): 721-725.doi: 10.12372/jcp.2022.22e0849
• Commentary • Next Articles
ZHOU Wei
Received:2022-06-15
Published:2022-10-15
Online:2022-10-12
ZHOU Wei. Diagnosis and treatment strategy of childhood-onset systemic lupus erythematosus[J].Journal of Clinical Pediatrics, 2022, 40(10): 721-725.
| [1] |
Tsokos GC. Systemic lupus erythematosus[J]. N Engl J Med, 2011, 365: 2110-2121.
doi: 10.1056/NEJMra1100359 |
| [2] | 周纬, 殷蕾, 金燕樑. 儿童系统性红斑狼疮临床特征(附47例报告)[J]. 上海医学, 2008, 31(12): 843-845. |
| [3] |
Kamphuis S, Silverman ED. Prevalence and burden of pediatric onset systemic lupus erythematosus[J]. Nat Rev Rheumatol, 2010, 6: 538-546.
doi: 10.1038/nrrheum.2010.121 pmid: 20683438 |
| [4] | 殷蕾, 周纬. 系统性红斑狼疮危象[J]. 中国小儿急救医学, 2020, 27(5): 324-329. |
| [5] | Kazzaz NM, Coit P, Lewis EE, et al. Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival[J]. Lupus Sci Med, 2015, 2(1): e000117. |
| [6] |
Ju JH, Min JK, Jung CK, et al. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE[J]. Nat Rev Rheumatol, 2009, 5(5): 273-281.
doi: 10.1038/nrrheum.2009.53 pmid: 19412194 |
| [7] |
Alperin JM, Ortiz-Fernández L, Sawalha AH. Monogenic lupus: a developing paradigm of disease[J]. Front Immunol, 2018, 9: 2496.
doi: 10.3389/fimmu.2018.02496 pmid: 30459768 |
| [8] |
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78: 1151-1159.
doi: 10.1136/annrheumdis-2018-214819 pmid: 31383717 |
| [9] |
Al-Mayouf SM, Akbar L, Abdwani R, et al. Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus[J]. Clin Rheumatol, 2022, doi: 10.1007/s10067-022-06209-9.
doi: 10.1007/s10067-022-06209-9 |
| [10] | 中华医学会儿科学分会免疫学组中华儿科杂志编辑委员会. 中国儿童系统性红斑狼疮诊断与治疗指南[J]. 中华儿科杂志, 2021, 59(12) : 1009-1024. |
| [11] |
Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus[J]. Arthritis Rheum, 1996, 39: 363-369.
doi: 10.1002/art.1780390303 |
| [12] |
Petri M, Magder LS. Comparison of remission and lupus low disease activity state in damage prevention in a United States systemic lupus erythematosus cohort[J]. Arthritis Rheumatol, 2018, 70: 1790-1795.
doi: 10.1002/art.40571 |
| [13] | Wahadat MJ, van den Berg L, Timmermans D, et al. LLDAS is an attainable treat-to-target goal in childhood-onset SLE[J]. Lupus Sci Med, 2021, 8(1): e000571. |
| [14] | FranklynK, LauCS, NavarraSV, et al. Definition and initial validation of a lupus low disease activity state (LLDAS)[J]. Anna Rheuma Dis, 2015, 75 (9): 1615. |
| [15] |
van Vollenhoven R, Voskuyl A, Bertsias G, et al. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)[J]. Ann Rheum Dis, 2017, 76: 554-561.
doi: 10.1136/annrheumdis-2016-209519 pmid: 27884822 |
| [16] |
Atar D, Birkeland KI, Uhlig T. 'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to heumatoid arthritis[J]. Ann Rheum Dis, 2010, 69: 629-630.
doi: 10.1136/ard.2010.128462 pmid: 20237122 |
| [17] |
Kumar K, Gordon C, Toescu V, et al. Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of south Asian and White British origin[J]. Rheumatology (Oxford), 2008, 47: 690-697.
doi: 10.1093/rheumatology/ken050 pmid: 18375972 |
| [18] | Mok CC, Hamijoyo L, Kasitanon N, et al. The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus[J]. Lancet Rheumatol, 2021, 3: e517-e531. |
| [19] |
Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review[J]. Ann Rheum Dis, 2010, 69: 20-28.
doi: 10.1136/ard.2008.101766 pmid: 19103632 |
| [20] |
Mok CC, Yap DY, Navarra SV, et al. Overview of lupus nephritis management guidelines and perspective from Asia[J]. Int J Rheum Dis, 2013, 16(6): 625-636.
doi: 10.1111/1756-185X.12212 pmid: 24382275 |
| [21] |
Buttgereit F, Straub RH, Wehling M, et al. Glucocorticoids in the treatment of rheumatic diseases:an update on the mechanisms of action[J]. Arthritis Rheum, 2004, 50: 3408-3417.
doi: 10.1002/art.20583 |
| [22] |
Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78: 736-745.
doi: 10.1136/annrheumdis-2019-215089 pmid: 30926722 |
| [23] | KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases[J]. Kidney Int, 2021, 100(4S): S1-S276. |
| [24] |
Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis[J]. N Engl J Med, 2005, 353: 2219-2228.
doi: 10.1056/NEJMoa043731 |
| [25] |
Isenberg D, Appel GB, Contreras G, et al. Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study[J]. Rheumatology (Oxford), 2010, 49: 128-140.
doi: 10.1093/rheumatology/kep346 pmid: 19933596 |
| [26] | 王笑秋, 殷蕾, 茅幼英, 等. 多靶点治疗儿童狼疮肾炎的疗效观察[J]. 中华风湿病学杂志, 2014, 18(9): 47-51. |
| [27] |
Weidenbusch M, Römmele C, Schröttle A, Anders HJ. Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis[J]. Nephrol Dial Transplant, 2013, 28: 106-111.
doi: 10.1093/ndt/gfs285 |
| [28] |
Lorenz G, Schul L, Schraml F, et al. Adult macro-phage activation syndrome-haemophagocytic lymphohistiocytosis: ‘of plasma exchange and immunosuppressive escalation strategies’ - a single centre reflection[J]. Lupus, 2020, 29: 324-333.
doi: 10.1177/0961203320901594 pmid: 32013725 |
| [1] | LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689. |
| [2] | ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697. |
| [3] | ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704. |
| [4] | WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711. |
| [5] | WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720. |
| [6] | HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726. |
| [7] | SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732. |
| [8] | Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608. |
| [9] | Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621. |
| [10] | LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627. |
| [11] | WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635. |
| [12] | GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643. |
| [13] | YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650. |
| [14] | HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488. |
| [15] | LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498. |
|
||